AEON Biopharma, Inc. (AEON) News
Track canonical SquawkNews coverage tagged to AEON, AEON Biopharma, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Fiscal Support Could Sustain Malaysia Consumer Spending — Market Talk
Malaysia's fiscal support could be doing the heavy lifting in sustaining consumer spending despite weaker sentiment, with private consumption growing 4.8% on year in 2Q, Hong Leong IB analyst Jonathan Ooi says in a note.
NEWS | Sep 29, 2026, 02:13 AM UTC
L
AEON pilot forced degradation results support ABP-450 comparability to BOTOX
AEON announced positive pilot forced degradation results supporting analytical comparability of ABP-450 to BOTOX.
EQUITY | Sep 09, 2026, 12:01 PM UTC
H
AEON Biopharma names Paul Lee acting chief regulatory officer
AEON Biopharma designates former FDA neuroscience leader Paul Lee, M.D., Ph.D. as acting chief regulatory officer.
REGULATION | Aug 24, 2026, 12:00 PM UTC
L
AEON reports expanded structural data for ABP-450
AEON says expanded structural data support molecular similarity of ABP-450 to BOTOX®; no magnitude, timing, or catalyst was supplied.
REGULATION | Aug 19, 2026, 12:00 PM UTC
L
AEON Biopharma Reports Q2 2026 Results
AEON Biopharma reports second quarter 2026 financial results and provides corporate update
EARNINGS | Aug 12, 2026, 08:15 PM UTC
M
AEON Regains NYSE Compliance
AEON meets NYSE American listing standards
EQUITY | Aug 03, 2026, 08:16 PM UTC
H
Why Aehr Test Systems Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Shares of Aehr Test Systems (NASDAQ: AEHR ) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY27 sales guidance above estimates. Aehr Test Sy
MACRO | Jul 15, 2026, 08:32 AM UTC
L
Aeon announces pricing of upsized $13.75M public offering
Aeon announces pricing of upsized $13.75M public offering
EQUITY | Jul 14, 2026, 02:13 PM UTC